Allphase Pharma Consulting, LLC
A Professional Service Provider for the Pharma Industry
There is hardly an indication which has accumulated more failed clinical trials than the sepsis area. Called first bacteremia, later sepsis, sepsis syndrome or septic shock, there have been numerous attempts to influence the cascade of events that eventually lead to MSOF and death. While it is convenient to think Continue reading Two New Approaches For Dealing with Sepsis / Toxemia
Despite all the concern about the emergence of CRE pathogens worldwide, it is quite difficult to obtain hard quantitative, prospectively collected incidence figures. A recent article by Robert [1] and colleagues provides useful data from France. Using a practical definition of carbapenem-non-susceptibility (ertapenem > 0.5, imipenem, meropenem > 2, doripenem > 1), Continue reading CRE Surveillance Data from France
It has grown with each edition, in page numbers, in weight, in numbers of contributors, diseases and pathogens described, and in complexity, with online access and search capabilities. More than most other therapeutic areas, the science of ID has grown in the past decades, thanks to advances in genetics, diagnostics Continue reading Fantastic – The 8th Edition of Mandell’s is Here!